Park Square Financial Group’s AbbVie ABBV Stock Holding History

Park Square Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$10.9K	–	211
2026 Q1	$10.9K	Buy	+50	New	+$11.1K	0.08%	83
2025 Q4	–	Sell	-174	Closed	-$40.3K	–	239
2025 Q3	$40.3K	Sell	174 -1,100	-86%	-$224K	0.17%	43
2025 Q2	$236K	Sell	1,274 -2	-0.2%	-$372	0.17%	93
2025 Q1	$267K	Buy	1,276 +204	+19%	+$39.7K	0.21%	68
2024 Q4	$190K	Buy	+1,072	New	+$197K	0.13%	98

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Park Square Financial Group's ABBV Position: Q2 2026 in Review

Park Square Financial Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 50 shares — an estimated $10.9K sold.

Park Square Financial Group first reported a position in ABBV in Q4 2024 and held it in 5 quarters. The position peaked at $267K in Q1 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Park Square Financial Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Park Square Financial Group sold 50 AbbVie shares in Q2 2026, an estimated $10.9K.
Park Square Financial Group first reported a position in AbbVie in Q4 2024 and held it in 5 quarters.
Park Square Financial Group's AbbVie position peaked at $267K in Q1 2025.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Park Square Financial Group's 13F filing for Q2 2026, filed 31 Jul 2026.